Leadership Development from ASCO

A board-certified hematologic oncology physician, Dr. Matthew Taub oversees patient care at Optimum Oncology Hematology Associates in Pembroke, Florida. Dr. Matthew Taub belongs to organizations that include the American Society of Clinical Oncology (ASCO).

One of the world's top medical organizations, ASCO supports physicians and other professionals who serve patients diagnosed with cancer. As part of its mission to ensure quality healthcare offerings, ASCO supplies numerous programs for clinical education, mentorship, and professional development.

Opportunities for professional development through ASCO include the Leadership Development Program, which is designed for individuals who have completed medical training in a subspecialty. The year-long program introduces participants to leadership techniques applicable in government, nonprofit, and clinical work.

During the year of training, students participate in advocacy in Congress, engage in a variety of interactive sessions, and receive guidance from ASCO mentors.

The Quality Training Program Offered by ASCO

Dr. Matthew Taub practices with Optimum Oncology Hematology Associates in Florida. Possessing more than 20 years of medical experience, Matthew Taub, MD, belongs to the American Society of Clinical Oncology (ASCO).

Since 1964, ASCO has been supporting physicians and oncology professionals. The organization offers numerous professional development activities, such as its Quality Training Program. This program is developed by oncology care specialists and oncologists to help oncology practice teams design, implement, and lead quality improvement activities in their practices.

The Quality Training Program combines hands-on learning with in-person sessions. The sessions take five days and include small group exercises and seminars to ensure that participants enjoy a well-rounded educational experience.

Completing the Quality Training Program allows participants to form high-functioning improvement teams at their practices, implement change strategies, and track quality performance over time. In addition, ASCO grants participants in the program credits toward their continuing education goals.

The NCCN Oncology Research Program

Hematologist Dr. Matthew Taub specializes in the diagnosis and treatment of blood cancers. As a physician with Optimum Oncology Hematology Associates, Dr. Matthew Taub follows treatment guidelines released by the National Comprehensive Cancer Network (NCCN).

As of 2018, NCCN has raised more than $30 million for trials of promising treatment options for multiple cancers, including hematologic malignancies, breast cancer, and sarcomas. In collaboration with research cancer centers, NCCN member institutions, and biotechnology and drug development companies, NCCN funds all phases of oncology-focused clinical trials through its Oncology Research Program (ORP). In addition to financial support, NCCN plays a major role in organizing and monitoring trials and results analysis and publishing study results. 

Recently, NCCN ORP was awarded $2 million by healthcare multinational Eli Lilly. The grant will fund research covering the process that underlies CDK4/6 resistance in advanced breast cancer patients.

The Work of the National Comprehensive Cancer Network

A strong believer in evidence-based medicine, Dr. Matthew Taub has treated people with a variety of cancers over the course of his 20-year career. Practicing at Optimum Oncology Hematology Associates in Pembroke Pines, Florida, Dr. Matthew Taub adheres to the guidelines of the National Comprehensive Cancer Network (NCCN) for decisions regarding chemotherapy and other treatments. 

A large part of the NCCN organization is its Oncology Research Program (ORP), which aims to enhance patient quality of life and reduce cancer-related deaths by advancing research in the field. To work toward its goals, ORP supports oncology preclinical, translational, and clinical research at NCCN member institutions. 

NCCN also actively works with industry drug developers to ensure effective communication across the industry. To date, NCCN ORP has allocated millions of dollars in research grants to fund investigator-initiated trials that push the boundaries of medical knowledge and seek answers to important research questions.

Memorial Hospital Miramar Nurtures Babies with Specially Designed NICU

An experienced oncologist and hematologist, Dr. Matthew Taub practices at Optimum Oncology Hematology Associates in Pembroke Pines, Florida. Matthew Taub, MD, is a member of the multidisciplinary committee at Memorial Hospital Miramar.

Located in Miramar, Florida, Memorial Hospital Miramar features a family birthing center and a level II Neonatal Intensive Care Unit (NICU) with 16 private patient rooms. Memorial Hospital Miramar NICU is equipped to care for neonates born at 28 weeks and later. 

The hospital invited a team of doctors, nurses, respiratory therapists, and parents to collaborate on the NICU design, which aims to provide an environment that feels like home. The unit has a special focus on privacy to allow bonding moments that nurture babies. In addition to the latest medical equipment, the NICU features ambient lighting that simulates night and day so babies develop a circadian rhythm that promotes healing and development.